Cargando…

A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study

BACKGROUND: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. METHODS AND FINDINGS: We measured plasma phospholipid fatty acids by gas chrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Imamura, Fumiaki, Sharp, Stephen J., Koulman, Albert, Schulze, Matthias B., Kröger, Janine, Griffin, Julian L., Huerta, José M., Guevara, Marcela, Sluijs, Ivonne, Agudo, Antonio, Ardanaz, Eva, Balkau, Beverley, Boeing, Heiner, Chajes, Veronique, Dahm, Christina C., Dow, Courtney, Fagherazzi, Guy, Feskens, Edith J. M., Franks, Paul W., Gavrila, Diana, Gunter, Marc, Kaaks, Rudolf, Key, Timothy J., Khaw, Kay-Tee, Kühn, Tilman, Melander, Olle, Molina-Portillo, Elena, Nilsson, Peter M., Olsen, Anja, Overvad, Kim, Palli, Domenico, Panico, Salvatore, Rolandsson, Olov, Sieri, Sabina, Sacerdote, Carlotta, Slimani, Nadia, Spijkerman, Annemieke M. W., Tjønneland, Anne, Tumino, Rosario, van der Schouw, Yvonne T., Langenberg, Claudia, Riboli, Elio, Forouhi, Nita G., Wareham, Nick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636062/
https://www.ncbi.nlm.nih.gov/pubmed/29020051
http://dx.doi.org/10.1371/journal.pmed.1002409
_version_ 1783270375361085440
author Imamura, Fumiaki
Sharp, Stephen J.
Koulman, Albert
Schulze, Matthias B.
Kröger, Janine
Griffin, Julian L.
Huerta, José M.
Guevara, Marcela
Sluijs, Ivonne
Agudo, Antonio
Ardanaz, Eva
Balkau, Beverley
Boeing, Heiner
Chajes, Veronique
Dahm, Christina C.
Dow, Courtney
Fagherazzi, Guy
Feskens, Edith J. M.
Franks, Paul W.
Gavrila, Diana
Gunter, Marc
Kaaks, Rudolf
Key, Timothy J.
Khaw, Kay-Tee
Kühn, Tilman
Melander, Olle
Molina-Portillo, Elena
Nilsson, Peter M.
Olsen, Anja
Overvad, Kim
Palli, Domenico
Panico, Salvatore
Rolandsson, Olov
Sieri, Sabina
Sacerdote, Carlotta
Slimani, Nadia
Spijkerman, Annemieke M. W.
Tjønneland, Anne
Tumino, Rosario
van der Schouw, Yvonne T.
Langenberg, Claudia
Riboli, Elio
Forouhi, Nita G.
Wareham, Nick J.
author_facet Imamura, Fumiaki
Sharp, Stephen J.
Koulman, Albert
Schulze, Matthias B.
Kröger, Janine
Griffin, Julian L.
Huerta, José M.
Guevara, Marcela
Sluijs, Ivonne
Agudo, Antonio
Ardanaz, Eva
Balkau, Beverley
Boeing, Heiner
Chajes, Veronique
Dahm, Christina C.
Dow, Courtney
Fagherazzi, Guy
Feskens, Edith J. M.
Franks, Paul W.
Gavrila, Diana
Gunter, Marc
Kaaks, Rudolf
Key, Timothy J.
Khaw, Kay-Tee
Kühn, Tilman
Melander, Olle
Molina-Portillo, Elena
Nilsson, Peter M.
Olsen, Anja
Overvad, Kim
Palli, Domenico
Panico, Salvatore
Rolandsson, Olov
Sieri, Sabina
Sacerdote, Carlotta
Slimani, Nadia
Spijkerman, Annemieke M. W.
Tjønneland, Anne
Tumino, Rosario
van der Schouw, Yvonne T.
Langenberg, Claudia
Riboli, Elio
Forouhi, Nita G.
Wareham, Nick J.
author_sort Imamura, Fumiaki
collection PubMed
description BACKGROUND: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. METHODS AND FINDINGS: We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991–1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested case-cohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of γ-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19–0.29) adjusted for potential confounders and 0.37 (95% CI 0.27–0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. CONCLUSIONS: A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors.
format Online
Article
Text
id pubmed-5636062
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56360622017-10-30 A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study Imamura, Fumiaki Sharp, Stephen J. Koulman, Albert Schulze, Matthias B. Kröger, Janine Griffin, Julian L. Huerta, José M. Guevara, Marcela Sluijs, Ivonne Agudo, Antonio Ardanaz, Eva Balkau, Beverley Boeing, Heiner Chajes, Veronique Dahm, Christina C. Dow, Courtney Fagherazzi, Guy Feskens, Edith J. M. Franks, Paul W. Gavrila, Diana Gunter, Marc Kaaks, Rudolf Key, Timothy J. Khaw, Kay-Tee Kühn, Tilman Melander, Olle Molina-Portillo, Elena Nilsson, Peter M. Olsen, Anja Overvad, Kim Palli, Domenico Panico, Salvatore Rolandsson, Olov Sieri, Sabina Sacerdote, Carlotta Slimani, Nadia Spijkerman, Annemieke M. W. Tjønneland, Anne Tumino, Rosario van der Schouw, Yvonne T. Langenberg, Claudia Riboli, Elio Forouhi, Nita G. Wareham, Nick J. PLoS Med Research Article BACKGROUND: Combinations of multiple fatty acids may influence cardiometabolic risk more than single fatty acids. The association of a combination of fatty acids with incident type 2 diabetes (T2D) has not been evaluated. METHODS AND FINDINGS: We measured plasma phospholipid fatty acids by gas chromatography in 27,296 adults, including 12,132 incident cases of T2D, over the follow-up period between baseline (1991–1998) and 31 December 2007 in 8 European countries in EPIC-InterAct, a nested case-cohort study. The first principal component derived by principal component analysis of 27 individual fatty acids (mole percentage) was the main exposure (subsequently called the fatty acid pattern score [FA-pattern score]). The FA-pattern score was partly characterised by high concentrations of linoleic acid, stearic acid, odd-chain fatty acids, and very-long-chain saturated fatty acids and low concentrations of γ-linolenic acid, palmitic acid, and long-chain monounsaturated fatty acids, and it explained 16.1% of the overall variability of the 27 fatty acids. Based on country-specific Prentice-weighted Cox regression and random-effects meta-analysis, the FA-pattern score was associated with lower incident T2D. Comparing the top to the bottom fifth of the score, the hazard ratio of incident T2D was 0.23 (95% CI 0.19–0.29) adjusted for potential confounders and 0.37 (95% CI 0.27–0.50) further adjusted for metabolic risk factors. The association changed little after adjustment for individual fatty acids or fatty acid subclasses. In cross-sectional analyses relating the FA-pattern score to metabolic, genetic, and dietary factors, the FA-pattern score was inversely associated with adiposity, triglycerides, liver enzymes, C-reactive protein, a genetic score representing insulin resistance, and dietary intakes of soft drinks and alcohol and was positively associated with high-density-lipoprotein cholesterol and intakes of polyunsaturated fat, dietary fibre, and coffee (p < 0.05 each). Limitations include potential measurement error in the fatty acids and other model covariates and possible residual confounding. CONCLUSIONS: A combination of individual fatty acids, characterised by high concentrations of linoleic acid, odd-chain fatty acids, and very long-chain fatty acids, was associated with lower incidence of T2D. The specific fatty acid pattern may be influenced by metabolic, genetic, and dietary factors. Public Library of Science 2017-10-11 /pmc/articles/PMC5636062/ /pubmed/29020051 http://dx.doi.org/10.1371/journal.pmed.1002409 Text en © 2017 Imamura et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Imamura, Fumiaki
Sharp, Stephen J.
Koulman, Albert
Schulze, Matthias B.
Kröger, Janine
Griffin, Julian L.
Huerta, José M.
Guevara, Marcela
Sluijs, Ivonne
Agudo, Antonio
Ardanaz, Eva
Balkau, Beverley
Boeing, Heiner
Chajes, Veronique
Dahm, Christina C.
Dow, Courtney
Fagherazzi, Guy
Feskens, Edith J. M.
Franks, Paul W.
Gavrila, Diana
Gunter, Marc
Kaaks, Rudolf
Key, Timothy J.
Khaw, Kay-Tee
Kühn, Tilman
Melander, Olle
Molina-Portillo, Elena
Nilsson, Peter M.
Olsen, Anja
Overvad, Kim
Palli, Domenico
Panico, Salvatore
Rolandsson, Olov
Sieri, Sabina
Sacerdote, Carlotta
Slimani, Nadia
Spijkerman, Annemieke M. W.
Tjønneland, Anne
Tumino, Rosario
van der Schouw, Yvonne T.
Langenberg, Claudia
Riboli, Elio
Forouhi, Nita G.
Wareham, Nick J.
A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
title A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
title_full A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
title_fullStr A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
title_full_unstemmed A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
title_short A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study
title_sort combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: the epic-interact case-cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636062/
https://www.ncbi.nlm.nih.gov/pubmed/29020051
http://dx.doi.org/10.1371/journal.pmed.1002409
work_keys_str_mv AT imamurafumiaki acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sharpstephenj acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT koulmanalbert acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT schulzematthiasb acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT krogerjanine acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT griffinjulianl acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT huertajosem acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT guevaramarcela acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sluijsivonne acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT agudoantonio acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT ardanazeva acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT balkaubeverley acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT boeingheiner acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT chajesveronique acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT dahmchristinac acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT dowcourtney acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT fagherazziguy acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT feskensedithjm acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT frankspaulw acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT gavriladiana acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT guntermarc acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT kaaksrudolf acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT keytimothyj acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT khawkaytee acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT kuhntilman acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT melanderolle acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT molinaportilloelena acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT nilssonpeterm acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT olsenanja acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT overvadkim acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT pallidomenico acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT panicosalvatore acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT rolandssonolov acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sierisabina acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sacerdotecarlotta acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT slimaninadia acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT spijkermanannemiekemw acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT tjønnelandanne acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT tuminorosario acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT vanderschouwyvonnet acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT langenbergclaudia acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT ribolielio acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT forouhinitag acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT warehamnickj acombinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT imamurafumiaki combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sharpstephenj combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT koulmanalbert combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT schulzematthiasb combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT krogerjanine combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT griffinjulianl combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT huertajosem combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT guevaramarcela combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sluijsivonne combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT agudoantonio combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT ardanazeva combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT balkaubeverley combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT boeingheiner combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT chajesveronique combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT dahmchristinac combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT dowcourtney combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT fagherazziguy combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT feskensedithjm combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT frankspaulw combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT gavriladiana combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT guntermarc combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT kaaksrudolf combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT keytimothyj combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT khawkaytee combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT kuhntilman combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT melanderolle combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT molinaportilloelena combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT nilssonpeterm combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT olsenanja combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT overvadkim combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT pallidomenico combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT panicosalvatore combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT rolandssonolov combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sierisabina combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT sacerdotecarlotta combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT slimaninadia combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT spijkermanannemiekemw combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT tjønnelandanne combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT tuminorosario combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT vanderschouwyvonnet combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT langenbergclaudia combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT ribolielio combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT forouhinitag combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy
AT warehamnickj combinationofplasmaphospholipidfattyacidsanditsassociationwithincidenceoftype2diabetestheepicinteractcasecohortstudy